DOCSLIB.ORG

Exploring Vigilance Notification for Organs

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Exploring Vigilance Notification for Organs NOTIFY - E xploring V igilanc E n otification for o rgans , t issu E s and c E lls NOTIFY Exploring VigilancE notification for organs, tissuEs and cElls A Global Consultation e 10,00 Organised by CNT with the co-sponsorship of WHO and the participation of the EU-funded SOHO V&S Project February 7-9, 2011 NOTIFY Exploring VigilancE notification for organs, tissuEs and cElls A Global Consultation Organised by CNT with the co-sponsorship of WHO and the participation of the EU-funded SOHO V&S Project February 7-9, 2011 Cover Bologna, piazza del Nettuno (photo © giulianax – Fotolia.com) © Testi Centro Nazionale Trapianti © 2011 EDITRICE COMPOSITORI Via Stalingrado 97/2 - 40128 Bologna Tel. 051/3540111 - Fax 051/327877 [email protected] www.editricecompositori.it ISBN 978-88-7794-758-1 Index Part A Bologna Consultation Report ............................................................................................................................................7 Part B Working Group Didactic Papers ......................................................................................................................................57 (i) The Transmission of Infections ..........................................................................................................................59 (ii) The Transmission of Malignancies ....................................................................................................................79 (iii) Adverse Outcomes Associated with Characteristics, Handling and Clinical Errors ..............................................99 (iv) Adverse Reactions in Donors ..........................................................................................................................119 (v) The Transmission of Genetic Diseases .............................................................................................................131 Part A Bologna Consultation Report 7 NOTIFY Exploring Vigilance Notification for Organs, Tissues and Cells Bologna, February 7-9, 2011 PARTICIPANTS Scientific Committee Chairmen Alessandro NANNI COSTA, Italian National Transplant Centre (Italy) Luc NOEL, World Health Organization (Switzerland) Mike STRONG, Notify Working Group Coordinator (USA) Deirdre FEHILY, Italian National Transplant Centre (Italy) Scientific Committee Scott A. BRUBAKER (USA) Matthew J. KUEHNERT (USA) Emanuele COZZI (Italy) Sophie LUCAS-SAMUEL (France) Carlo DE CILLIA (Italy) Rafael MATESANZ (Spain) Francis DELMONICO (USA) Dietger NIEDERWIESER (Germany) Antonia DERRICO (Italy) Francesco PROCACCIO (Italy) Beatriz DOMINGUEZ-GIL (Spain) Axel RAHMEL (The Netherlands) Luca GIANAROLI (Italy) Lorenza RIDOLFI (Italy) Walter Francesco GRIGIONI (Italy) Lucia RIZZATO (Italy) Paolo GROSSI (Italy) Naoshi SHINOZAKI (Japan) Organizing Committee Paola DI CIACCIO (Italy) Claudia CARELLA (Italy) Deirdre FEHILY (Italy) Conference Agency Donatella PARIALI (Italy) Working Group Leaders Group 1: Organs Paolo Grossi, Frank Delmonico, Matthew Kuehnert Group 2: Tissues (other than ocular) Ted Eastlund, Johann Kurz, Maurice Hinsenkamp Group 3: Haematopoietic Stem Cells (HPC) Dietger Niederwieser, Laura St Martin, Kathy Loper Group 4: Ocular Tissues Naoshi Shinosaki, Marian Macsai, Paul Dubord Group 5: Gametes and Embryos Luca Gianaroli, Mauro Costa, Anne Cathrine Bollerup Group 6: Infection Jay A. Fishman, Michael G. Ison, Richard Tedder Group 7: Malignancy Jeremy Chapman, Rafael Matesanz, Antonietta Derrico Grigioni Group 8: Product Properties Diego Ponzin, Scott Brubaker, Axel Rahmel 9 Group 9: Clinical Practice. Lorenza Ridolfi, Rene de Vries, Paula Nolan Group 10: Genetic and Donor Emanuele Cozzi, Carolina Stylianou, Dennis Confer Rapporteurs Frances DELANEY (Luxembourg) Lead Rapporteur Michael G. ISON (USA) (Organs) Mauro COSTA (Italy) (Gametes and Embryos) Mike STRONG (USA) (HPC) Deirdre FEHILY (Italy) (Tissues) Other participants: Anil AGARWAL (India), Ines ALVAREZ SALDIAS (Uruguay), Margarida AMIL (Portugal), Fiorenza BARIANI (Italy), Tommaso BELLANDI (Italy), Anne-Cathrine BOLLERUP (Denmark), Pavel BREZOVSKY (Czech Republic), Audrone BÜZIUVIENE (Lithu- ania), Marina BUZZI (Italy), Gorazd C ˇ EBULC (Slovenia), Jeremy R. CHAPMAN (Australia), Bernard COHEN (Belgium), Dennis L. Confer (USA), Jane COOK (Australia), Daniel R. CORADI FREITAS (Brazil), Michael COX (Denmark), Hervé CREUSVAUX (France), Vibeke DALEN (Norway), Filip DANNINGER (Slovak Republic), Jennifer DE MATTEO (USA), Renè DE VRIES (The Netherlands), Visist DHITAVAT (Thailand), Paul DUBORD (Canada), Małgorzata DUDKIEWICZ (Poland), David EASTLUND (USA), Susie ELSAADANY (Canada), Jay A. FISHMAN (USA), Presmyl FRYDA (Czech Republic), Jacques Olivier GALBART (France), Christian GARZONI (Switzerland), Maria GICHEVA (Bulgaria), Angelo GHIRARDINI (Italy), Marjan HAPPEL (The Netherlands), Donna HARKIN (Ireland), Tomonori HASEGAWA (Japan), Charlotte HENRIKSEN (Denmark), Maurice HY- SENKAMP (Belgium), Stefano INGLESE (Italy), Hilga KATERBERG (The Netherlands), Hauwa J. KERI (Nigeria), Guenter KIRSTE (Germany), Yvonne KOH (Singapore), Jan KOLLER (Slovakia), Johann KURZ (Austria), Letizia LOMBARDINI (Italy), Kathy LOPER (USA), Marian MACSAI (USA), Mitra MAHDAVI-MAZDEH (Iran), Diane MALONEY (USA), Martí MANYALICH (Spain), Rosario MARAZUELA (Spain), Elmi MULLER (South Africa), Vanja NIKOLAC (Croatia), Christiane NIEDERLAENDER (UK), Paula NOLAN (UK), Olga ORLOVA (Russia), Marie-Odile OTT (Council of Europe), Alessandro PACINI (Italy), Annarita PANEBIANCO (Italy), Jordan PEEV (Bulgaria), Giuseppe PICCOLO (Italy), Roberto PERESSUTTI (Italy), Diego PONZIN (Italy), Eliana PORTA (Italy), Tim PRUETT (USA), Leo ROELS (Belgium), Giuseppe RUOCCO (Italy), Giulia SCARAVELLI (Italy), Bron- wen SHAW (UK), Mike SMITH (Belgium), Olga SOLOMON (European Commission), Laura ST. MARTIN (USA), Kellathur N SRINIVASAN (Singapore), Kristina STANKOVIC ´ (Croatia), Daniela STORANI (Italy), Carolina Stylianou (Cyprus), Richard Tedder (UK), Fewzi TESKRAT (France), Esteve TRIAS (Spain), Izabela UHRYNOWSKA-TYSZKIEWICZ (Poland), Assen VELKOV (Bulgaria), Ruth WARWICK (UK), Jan WONDERGEM (Austria), Jun WU (Canada), Richard ZAMMIT (Malta), Victor-Gheorhe ZOTA (Romania) 10 Table of Contents Preamble .......................................................................................................................................................................13 1. Opening session and background .............................................................................................................................15 1.1. Introduction .....................................................................................................................................................15 1.2. CTO Vigilance at CNT .......................................................................................................................................15 1.3. CTO Vigilance and Surveillance in WHO ...........................................................................................................16 1.4. SOHO Vigilance in the EU .................................................................................................................................17 1.5. Lessons learned from 7 years of experience: Biovigilance as part of SOHO vigilance ..........................................18 1.6. From EUSTITE to SOHO V&S with WHO ............................................................................................................18 1.7. Traceability and Biovigilance in the USA ............................................................................................................19 2. V&S: Communication for Action. An exploration of vigilance developments around the globe. ................................21 2.1. ART vigilance in France: overview of a new vigilance system .............................................................................21 2.2. V&S in Brazil: link with clinicians and achievements ..........................................................................................21 2.3. Haematopoietic stem cell donor reactions and events .......................................................................................22 2.4. 50 years of cornea vigilance by the Eye Banking Association of America ...........................................................22 2.5. EFRETOS: EU organ project with V&S as part of recipient follow-up ..................................................................24 2.6. V&S for SOHO in Singapore ..............................................................................................................................25 2.7. Croatia, the challenge of establishing a SOHO V&S system ...............................................................................26 2.8. AATB guidance on ‘Identifying, reporting, and investigating tissue recipient adverse reactions’ .........................27 3. Engaging all relevant stakeholders in V&S. ................................................................................................................28 3.1. FDA and Biovigilance ........................................................................................................................................28 3.2. Italy’s outreach to transplant clinicians, recipients, donors and the public ..........................................................28 3.3. The significance of serious adverse events in tissue and cell vigilance ................................................................29 3.4. Vigilance notification
Load more

Recommended publications
  • Euro GTP Guidance
    EURO­GTP Euro GTP Guidance European Union Project in the framework of the Public Health Program Agreement number: 2007 207 Coordinator: Transplant Services Foundation 1 List of Authors ‐ Euro GTP Project Coordinator TSF ▪ Transplant Services Foundation | Spain Project Partners BISLIFE | Netherlands BTV ▪ Banca Tessuti della Regione Veneto | Italy CBC ▪ Hornhautbank Berlin Charite Universitatsmedizin | Germany EHB ▪ European Homograft Bank | Belgium ESB ▪ Euro Skin Bank | Netherlands HBM ▪ Hornhautbank München Gemeinnutzige | Germany ISS‐CNT ▪ Istituto Superiore di Sanita Centro Nazionale Trapianti | Italy KCBTiK ▪ Krajowe Centrum Bankowania Tkanek I Komórek | Poland QAMH ▪ Queen Astrid Military Hospital | Belgium REGEA ▪ Tampere Yliopisto. University of Tampere | Finland i Table of Contents PURPOSE AND SCOPE ................................................................................................................................................1 SECTION A: GENERAL REQUIREMENTS .......................................................................................................................3 A.1. PERSONNEL ............................................................................................................................................................... 3 A.2. FACILITIES AND EQUIPMENT ..................................................................................................................................... 8 A.2.1. FACILITIES, EQUIPMENT AND MATERIALS FOR RECOVERY...............................................................................
    [Show full text]
  • Ethical, Legal and Psychosocial Aspects of Transplantation Global Challenges
    E. K. Massey, F. Ambagtsheer, W. Weimar (Eds.) Ethical, Legal and Psychosocial Aspects of Transplantation Global Challenges PABST E. K. Massey, F. Ambagtsheer, W. Weimar (Eds.) Ethical, Legal and Psychosocial Aspects of Transplantation Global Challenges PABST SCIENCE PUBLISHERS Lengerich Bibliographic information published by Die Deutsche Nationalbibliothek Die Deutsche Nationalbibliothek lists this publication in the Deutsche Nationalbibliografie; detailed bibliographic data is available in the Internet at <http://dnb.ddb.de>. This work is subject to copyright. All rights are reserved, whether the whole or part of the mate- rial is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in other ways, and storage in data banks. The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a spe- cific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The authors and the publisher of this volume have taken care that the information and recommen- dations contained herein are accurate and compatible with the standards generally accepted at the time of publication. Nevertheless, it is difficult to ensure that all the information given is entirely accurate for all circumstances. The publisher disclaims any liability, loss, or damage incurred as a consequence, directly or indirectly, of the use and application of any of the contents of this volume. © 2017 Pabst Science Publishers · D-49525 Lengerich Internet: www.pabst-publishers.de, www.pabst-science-publishers.com E-mail: [email protected] Print: ISBN 978-3-95853-292-2 eBook: ISBN 978-3-95853-293-9 (www.ciando.com) Formatting: µ Printed in Germany by KM-Druck, D-64823 Gross-Umstadt Contents Preface Introduction Emma K.
    [Show full text]
  • Freezing of Surplus Donated Whole Eyes in the Central Eye Bank of Iran
    RESEARCH Freezing of Surplus Donated Whole Eyes in the Central Eye Bank of Iran Use of Defrosted Corneas for Deep Anterior Lamellar Keratoplasty and Report of Postoperative Eye Bank Data Mozhgan Rezaei Kanavi, MD; Mohammad Ali Javadi, MD; Fatemeh Javadi; Tahereh Chamani, MS ABSTRACT especially when a shortage exists for fresh donor corneas for transplantation. PURPOSE: To describe the method of freezing and thaw- KEYWORDS: cornea, freezing, whole eyes, DALK, ing of donated whole eyes (DWEs), which were surplus to eye banks, thawing....................................... requirements in the Central Eye Bank of Iran (CEBI), and to report the 3-year results of using defrosted corneas in deep anterior lamellar keratoplasty (DALK) in keratoconic eyes. he Central Eye Bank of Iran (CEBI) is the METHODS: The method of freezing and thawing of only eye bank in Iran and is located in Tehran. surplus DWEs in the CEBI is described. Surplus DWEs Tissue requirements for corneal and scleral at the CEBI were disinfected, processed, and transferred T transplantation in Iran are supplied and preserved to the freezer (-70°C) for long-term preservation. In case 1 of a shortage of fresh and refrigerated corneas for DALK, by the CEBI. There has been an increasing trend in a frozen DWE was defrosted and distributed for trans- corneal transplantation in Iran, from 200 grafts in plantation either as a whole eye in moist chamber or as 1988 to 6,053 in 2012 (unpublished data). Keratoco- an excised corneoscleral disc in Eusol C at 2˚C to 8˚C. nus is the most common indication for penetrating Furthermore, eye bank data of the frozen DWEs as well 1 as postoperative eye bank reports of implementation of keratoplasty in Iran, accounting for 34.5% of cases.
    [Show full text]
  • The Dynamic Nordic Region Looking Back at the Past Year in the Nordic Council 2004And Nordic Council of Ministers
    The Dynamic Nordic Region Looking back at the past year in the Nordic Council 2004and Nordic Council of Ministers 1 The Dynamic Nordic Region Looking back at the past year in the Nordic Council 2004and Nordic Council of Ministers The photographs in this annual report were taken during the Ses- Photos sion of the Nordic Council in Stockholm in early November 2004. Johan Gunséus cover, pp. 2, 5, 7-, 8, 11, 13, 14, 17, 18, The annual Session brings together parliamentarians, ministers, 21, 22, 23, 26, 31, 32, 37. journalists, civil servants and international guests for three days Magnus Fröderberg pp. 1, 4 (2nd from left), 16, 29, 35. of hectic and intense activity, meetings and debate. Personal Johannes Jansson p. 4 (1st from left). exchanges of opinions and ideas are an integral part of the Nordic democratic process. The Dynamic Nordic Region The Nordic Council and Nordic Council of Ministers 2004 Further information: Please contact the Information Department: ANP 2005:705 www.norden.org/informationsavdelningen © The Nordic Council and Nordic Council of Ministers, E-mail [email protected] Copenhagen 2005 Fax (+45) 3393 5818 ISBN 92-893-1109-6 Nordic co-operation Printer: Scanprint as, Århus 2005 Nordic co-operation, one of the oldest and most wide-ranging Production controller: Kjell Olsson regional partnerships in the world, involves Denmark, Finland, Design: Brandpunkt a/s Iceland, Norway, Sweden, the Faroe Islands, Greenland and the Copies: 1,500 Åland Islands. Co-operation reinforces the sense of Nordic commu- Printed on 130 g Arctic the Volume, environmentally friendly paper nity, while respecting national differences and similarities, makes as per the Nordic Swan labelling scheme.
    [Show full text]
  • Research : Code of Practice and Standards
    �;HTA • Human Tissue Authority £ Research Code of Practice and Standards Published: 3 April 2017 Code E: Research Contents Introduction to the Human Tissue Authority Codes of Practice .................................. 3 Introduction to the Research Code ............................................................................. 5 The role of HTA in regulating research under the Human Tissue Act 2004 ............ 5 Scope of this Code .................................................................................................. 5 Offences under the HT Act ...................................................................................... 6 Structure and navigation ......................................................................................... 6 Relevant material and research ................................................................................. 7 What is research? ................................................................................................... 7 What is relevant material? ....................................................................................... 7 Access to tissue from the living ............................................................................... 9 Access to tissue from the deceased ..................................................................... 10 Research involving stillborn babies or infants who have died in the neotatal period .. 11 Consent ...................................................................................................................
    [Show full text]
  • Four Cases of Corneal Perforation in Patients with Chronic Graft- Versus-Host Disease
    Molecular Vision 2011; 17:598-606 <http://www.molvis.org/molvis/v17/a68> © 2011 Molecular Vision Received 21 October 2010 | Accepted 15 February 2011 | Published 25 February 2011 Four cases of corneal perforation in patients with chronic graft- versus-host disease Emi Inagaki, Yoko Ogawa, Yukihiro Matsumoto, Tetsuya Kawakita, Shigeto Shimmura, Kazuo Tsubota Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan Purpose: To report the clinical features and investigate the underlying pathological processes of spontaneous corneal perforation in patients with ocular chronic graft-versus-host disease (cGVHD). Methods: A full ophthalmological evaluation of corneal perforation in four patients with cGVHD was performed. Three of them underwent deep anterior lamellar keratoplasty and samples from two of three patients were used for histopathological analyses. Results: Three patients were successfully treated by corneal transplantation. One patient was treated with a therapeutic soft contact lens, and the wound healed within 2 days. The common clinical features of these patients were (1) the presence of definite dry eye related to cGVHD in 3 of 4 patients and probable dry eye in one patient, (2) a central or paracentral site of corneal ulceration and perforation, with no sign of infection, and (3) prior use of a topical or systemic corticosteroid, and/or topical non-steroidal anti-inflammatory drugs. Immunohistochemical findings revealed an increased number of cluster of differentiation 68+ (CD68+) macrophages and matrix metalloproteinase 9 (MMP-9) expression in the tissue surrounding the perforation. Conclusions: Our report extends current information on the clinical features and pathological processes of corneal perforation in cGVHD by showing increased MMP-9 expression and the accumulation of CD68+ positive macrophages in the affected areas.
    [Show full text]
  • Fast Facts & Stats
    FAST FACTS & STATS “Of all the senses, sight must be the most delightful.” ~ Helen Keller More sensory neurons are dedicated to vision than the other four senses combined, and giving the gift of sight – through cornea donation – can be life-giving and life-changing. But what does it really mean? “Eye donation” doesn’t mean the entire eye is transplanted; instead, only the cornea (the clear, dome-shaped surface that covers the front of the eye) is replaced, restoring sight for those with cornea-related blindness. The entire eye can be used for research and education, potentially helping untold thousands of people regain their sight as researchers gain new understanding of the cause and effects of eye conditions that lead to blindness. Historical facts: · The first human corneal transplant was performed in 1905 by Dr. Eduard Zirm in Olomouc, Czechoslovakia. · The first U.S. transplant was performed in New York City by Dr. R. Townley Paton in 1937. · The first eye bank – a non-profit organization that recovers, evaluates, prepares and distributes eyes donated for use in corneal transplantation, research and education – opened in 1944 in New York City. · The Eye Bank Association of America, established in 1961, is the oldest transplant association and was formed by a group of ophthalmologists and eye bankers. Statistics: · 50,930: Number of corneas provided for transplant in the U.S. in 2017, meeting 100% of U.S. demand. · 33,367: Number of corneas exported, helping restore sight worldwide. · 12 million: Corneal disease cases worldwide that result in blindness or visual impairment— and that could be reversed with cornea transplants.
    [Show full text]
  • 3Rd Quarter 2001 Bulletin
    In This Issue... Promoting Colorectal Cancer Screening Important Information and Documentaion on Promoting the Prevention of Colorectal Cancer ....................................................................................................... 9 Intestinal and Multi-Visceral Transplantation Coverage Guidelines and Requirements for Approval of Transplantation Facilities12 Expanded Coverage of Positron Emission Tomography Scans New HCPCS Codes and Coverage Guidelines Effective July 1, 2001 ..................... 14 Skilled Nursing Facility Consolidated Billing Clarification on HCPCS Coding Update and Part B Fee Schedule Services .......... 22 Final Medical Review Policies 29540, 33282, 67221, 70450, 76090, 76092, 82947, 86353, 93922, C1300, C1305, J0207, and J9293 ......................................................................................... 31 Outpatient Prospective Payment System Bulletin Devices Eligible for Transitional Pass-Through Payments, New Categories and Crosswalk C-codes to Be Used in Coding Devices Eligible for Transitional Pass-Through Payments ............................................................................................ 68 Features From the Medical Director 3 he Medicare A Bulletin Administrative 4 Tshould be shared with all General Information 5 health care practitioners and managerial members of the General Coverage 12 provider/supplier staff. Hospital Services 17 Publications issued after End Stage Renal Disease 19 October 1, 1997, are available at no-cost from our provider Skilled Nursing Facility
    [Show full text]
  • Xenotransplantation: Past, Present, and Future
    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Curr Opin Manuscript Author Organ Transplant Manuscript Author . Author manuscript; available in PMC 2018 December 01. Published in final edited form as: Curr Opin Organ Transplant. 2017 December ; 22(6): 513–521. doi:10.1097/MOT.0000000000000463. XENOTRANSPLANTATION: PAST, PRESENT, AND FUTURE Burcin Ekser, MD, PhD1, Ping Li, PhD1, and David K.C. Cooper, MD, PhD2 1Division of Transplant Surgery, Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA 2Xenotransplantation Program, Department of Surgery, The University of Alabama at Birmingham, Birmingham, AL, USA Abstract Purpose of review—To review the progress in the field of xenotransplantation with special attention to most recent encouraging findings which will eventually bring xenotransplantation to the clinic in the near future. Recent findings—Starting from early 2000, with the introduction of Gal-knockout pigs, prolonged survival especially in heart and kidney xenotransplantation was recorded. However, remaining antibody barriers to nonGal antigens continue to be the hurdle to overcome. The production of genetically-engineered pigs was difficult requiring prolonged time. However, advances in gene editing, such as zinc finger nucleases, transcription activator-like effector nucleases, and most recently CRISPR technology made the production of genetically-engineered pigs easier and available to more researchers. Today, the survival of pig-to-nonhuman primate heterotopic heart, kidney, and islet xenotransplantation reached >900 days, >400 days, and >600 day, respectively. The availability of multiple-gene pigs (5 or 6 genetic modifications) and/or newer costimulation blockade agents significantly contributed to this success. Now, the field is getting ready for clinical trials with an international consensus.
    [Show full text]
  • A Stronger Region the Nordic Council and Nordic Council of Ministers 2006 06
    Modern partnerships for a stronger Region The Nordic Council and Nordic Council of Ministers 2006 06 06 Photos pp. 2, 25, 40: Pictures from “Reflections in the Northern Sky” – the international culture festival for indigenous peoples, held in Estonia. Photos pp. 2, 25 and 40: Kersti Sepper. Inset p. 25: Tiiu Kirsipuu. Front cover: The Gogmagogs music ensemble (part of the “Distur- Nordic cultural co-operation was reformed radically at the end of bances” Nordic music symposium). PR shot. Back cover (small 2006. Several institutions were discontinued and Nordic Culture pictures): Burst. Photo: G. Magni Agústsson; Vertebra. Photo: Petri Point was set up with a mandate to run multi-national and multi- Heikkilä; URGE. Photo: Ulrik Wivel; Polaroid. Photo: © Jo Strømgren genre programmes. The annual report features photographs Kompani. Photo (right): The Madman’s Garden, Martin Sirkovsky. illustrating various aspects of the multi-facetted cultural collabora- Photos pp. 1, 3, 28–29: Magnus Frölander (MF). Photos pp. 4, 9: tion that goes on under Nordic auspices or with official Nordic Johannes Jansson (JJ). Photos pp. 16–17: JJ; JJ; MF; JJ; MF; MF; MF; support. The worlds of dance, opera, poetry and the theatre are MF; MF; MF; MF; MF; JJ; JJ; MF. all portrayed along with a depiction of the Nordic Computer Games programme. The photographs are from the Faroe Islands in the west all the way to Latvia in the east and include a collage from the Annual Session of the Nordic Council in Copenhagen. Modern partnerships for a stronger Region The Nordic Council and Nordic Council of Ministers 2006 ANP 2007:717 © The Nordic Council and Nordic Council of Ministers, Copenhagen 2007 ISBN 978-92-893-192-3 Print: Saloprint A/S, Copenhagen 2007 Design: Par No 1 A/S Copies: 800 Printed on environmentally friendly paper Printed in Denmark Nordic co-operation Nordic co-operation, one of the oldest and most wide-ranging regional partnerships in the world, involves Denmark, Finland, Iceland, Norway, Sweden, the Faroe Islands, Greenland and the Åland Islands.
    [Show full text]
  • EBAA Medical Standards – October 2016
    Medical Standards These Standards have the approval of the Eye Banking Committee of the American Academy of Ophthalmology October 28, 2016 Published by: EBAA th 1015 18 Street, NW, Suite 1010, Washington, DC 20036, USA www.restoresight.org ©2016. EBAA. All rights reserved. Page 1 EBAA Medical Standards – October 2016 Table of Contents A1.000 Introduction and Purpose ..............................................................................................5 A1.100 Scope ......................................................................................................................5 B1.000 Active Membership .........................................................................................................5 B1.100 Eye Bank Inspection...............................................................................................6 B1.200 Inspections by Official Agencies ...........................................................................6 C1.000 Personnel and Governance .............................................................................................6 C1.100 Director...................................................................................................................6 C1.200 Medical Director ....................................................................................................7 C1.300 Staff Performing Eye Banking Functions ..............................................................8 C1.400 Change in Governance ...........................................................................................9
    [Show full text]
  • Ethical Issues in Living-Related Corneal Tissue Transplantation
    Viewpoint Ethical issues in living-related corneal J Med Ethics: first published as 10.1136/medethics-2018-105146 on 23 May 2019. Downloaded from tissue transplantation Joséphine Behaegel, 1,2 Sorcha Ní Dhubhghaill,1,2 Heather Draper3 1Department of Ophthalmology, ABSTRact injury, typically chemical burns, chronic inflamma- Antwerp University Hospital, The cornea was the first human solid tissue to be tion and certain genetic diseases, the limbal stem Edegem, Belgium 2 transplanted successfully, and is now a common cells may be lost and the cornea becomes vascula- Faculty of Medicine and 5 6 Health Sciences, Dept of procedure in ophthalmic surgery. The grafts come from rised and opaque, leading to blindness (figure 1). Ophthalmology, Visual Optics deceased donors. Corneal therapies are now being In such cases, standard corneal transplants fail and Visual Rehabilitation, developed that rely on tissue from living-related donors. because of the inability to maintain a healthy epithe- University of Antwerp, Wilrijk, This presents new ethical challenges for ophthalmic lium. Limbal stem cell transplantation is designed to Belgium 3Division of Health Sciences, surgeons, who have hitherto been somewhat insulated address this problem by replacing the damaged or Warwick Medical School, from debates in transplantation and donation ethics. lost limbal stem cells (LSC) and restoring the ocular University of Warwick, Coventry, This paper provides the first overview of the ethical surface, which in turn increases the success rates of United Kingdom considerations generated by ocular tissue donation subsequent sight-restoring corneal transplants.7 8 from living donors and suggests how these might Limbal stem cell donations only entail the removal Correspondence to be addressed in practice.
    [Show full text]